Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis.
Villar-Taibo R, Galdón Sanz-Pastor A, Fernández-Rubio E, Barajas Galindo D, Simó Servat A, Ampudia-Blasco FJ. Villar-Taibo R, et al. Among authors: ampudia blasco fj. Diabetes Technol Ther. 2024 Aug;26(8):575-586. doi: 10.1089/dia.2023.0524. Epub 2024 Apr 15. Diabetes Technol Ther. 2024. PMID: 38502158
Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes.
Cuerda Del Pino A, Martín-San Agustín R, José Laguna Sanz A, Díez JL, Palanca A, Rossetti P, Gumbau-Gimenez M, Ampudia-Blasco FJ, Bondia J. Cuerda Del Pino A, et al. Among authors: ampudia blasco fj. Diabetes Technol Ther. 2024 Jun;26(6):411-419. doi: 10.1089/dia.2023.0535. Diabetes Technol Ther. 2024. PMID: 38215205
Current barriers to initiating insulin therapy in individuals with type 2 diabetes.
Galdón Sanz-Pastor A, Justel Enríquez A, Sánchez Bao A, Ampudia-Blasco FJ. Galdón Sanz-Pastor A, et al. Among authors: ampudia blasco fj. Front Endocrinol (Lausanne). 2024 Mar 14;15:1366368. doi: 10.3389/fendo.2024.1366368. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38559691 Free PMC article. Review.
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study.
Palanca A, Ampudia-Blasco FJ, Calderón JM, Sauri I, Martinez-Hervás S, Trillo JL, Redón J, Real JT. Palanca A, et al. Among authors: ampudia blasco fj. Diabetes Res Clin Pract. 2024 Jan;207:111071. doi: 10.1016/j.diabres.2023.111071. Epub 2023 Dec 22. Diabetes Res Clin Pract. 2024. PMID: 38142748
Physical activity patterns in type 1 diabetes in Spain: The SED1 study.
Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A; SED and SED1 study investigators. Gómez-Peralta F, et al. BMC Sports Sci Med Rehabil. 2023 Jul 26;15(1):92. doi: 10.1186/s13102-023-00695-3. BMC Sports Sci Med Rehabil. 2023. PMID: 37491278 Free PMC article.
Association of carotid atheroma plaque with IL-18 levels and with polymorphisms in the IL-18 receptor gene in a Mediterranean population.
Palanca A, Bartual-Rodrigo A, Cuenca C, Mayo-López OD, Ampudia-Blasco FJ, González-Navarro H, Ascaso JF, García-García AB, Chaves FJ, Real JT, Martínez-Hervás S. Palanca A, et al. Among authors: ampudia blasco fj. Clin Investig Arterioscler. 2024 Jul-Aug;36(4):210-217. doi: 10.1016/j.arteri.2023.12.005. Epub 2024 Jan 11. Clin Investig Arterioscler. 2024. PMID: 38216380 English, Spanish.
Effect of personality on blood glucose control in patients with type 1 diabetes.
Gu Hong WC, Ferri J, Ampudia-Blasco FJ, Martín-Brufau R, Peiró M, Benito E, Martinez-Hervas S, Sanz MJ, Real JT. Gu Hong WC, et al. Among authors: ampudia blasco fj. Endocrinol Diabetes Nutr (Engl Ed). 2022 Nov;69(9):677-685. doi: 10.1016/j.endien.2021.11.034. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 36470643
70 results